Anatomy Of A Merger War: Valeant, Ackman Vs. Allergan
Activist investor Bill Ackman this week took a harder line in his campaign to push Allergan Inc. into a $53.3 billion tie-up with rival Valeant Pharmaceuticals International Inc., and this latest...To view the full article, register now.
Already a subscriber? Click here to view full article